Ability P&O — Exton, Pennsylvania

Ability P&O is a clinical research site located in Exton, Pennsylvania, United States 19341.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Ability P&O has participated in 1 clinical trials.

Therapeutic areas: Lower Limb Amputation Below Knee (Injury), Lower Limb Amputation Above Knee (Injury), Lower Limb Amputation Knee.

Sponsors: Otto Bock Healthcare Products GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Exton

Browse all research sites in Pennsylvania · View every site in Exton

• Main Line Health Center-Exton
• Dermatology and Skin Surgery Center
• The Pennsylvania Centre for Dermatology, LLC
• Center for Interventional Pain & Spine
• Research Site
• Arcutis Biotherapeutics Clinical Site 113
• Various
• Foamix Investigational Site # 224
• Novartis Investigative Site
• Dermatology and Skin Surgery Center, PC
• Clinical Renal Associates
• 50 Sites

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ability P&O?

Ability P&O has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ability P&O conducted?

Ability P&O has 1 clinical trials on record. Their work covers Lower Limb Amputation Below Knee (Injury), Lower Limb Amputation Above Knee (Injury), Lower Limb Amputation Knee.

Is Ability P&O accredited by Crixeo Clinical Trials?

Ability P&O has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ability P&O?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.